Financial Summary (All financials)
In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 0.0 | 0.0 | 15.0 | 66.1 | 0.0 | 0.0 | 2.6 | 0.2 |
Revenue growth | | -100.0% | -77.3% | | | -100.0% | 955.5% | -89.9% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 15.0 | 66.1 | 0.0 | 0.0 | 2.6 | 0.2 |
Gross margin | | | 100.0% | 100.0% | | | 100.0% | 100.0% |
Research and development | 50.1 | 63.6 | 56.8 | 56.6 | 53.5 | 46.7 | 39.0 | 35.4 |
General and administrative | 23.9 | 26.0 | 23.0 | 24.7 | 15.9 | 12.7 | 10.9 | 9.2 |
EBIT | -74.0 | -89.6 | -64.9 | -15.1 | -69.4 | -59.5 | -47.3 | -44.3 |
EBIT margin | | | -432.4% | -22.8% | | | -1814.1% | -17954.3% |
Pre-tax income | -70.3 | -85.2 | -61.7 | -5.0 | -69.0 | -58.9 | -47.1 | -44.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -70.3 | -85.2 | -61.7 | -5.0 | -69.0 | -58.9 | -47.1 | -44.2 |
Net margin | | | -411.4% | -7.6% | | | -1807.7% | -17897.2% |
|
Diluted EPS | ($0.51) | ($0.62) | ($0.45) | ($0.04) | ($0.70) | ($0.63) | ($0.64) | ($0.69) |
Shares outstanding (diluted) | 138.4 | 137.2 | 136.7 | 125.6 | 98.4 | 94.0 | 74.0 | 64.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|